[
    {
        "title": "Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa - Yahoo Finance",
        "description": "Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa  Yahoo Finance",
        "published date": "Thu, 14 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9raW9yYS1waGFybWFjZXV0aWNhbHMtcHJlc2VudC10b3BsaW5lLXJlc3VsdHMtMTEwMTAwNjA4Lmh0bWzSAWNodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9raW9yYS1waGFybWFjZXV0aWNhbHMtcHJlc2VudC10b3BsaW5lLXJlc3VsdHMtMTEwMTAwNjA4Lmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]